<DOC>
	<DOCNO>NCT00410293</DOCNO>
	<brief_summary>Diagnostic uncertainty patient complaint shortness breath present Emergency Department hospital may delay treatment proper care . In patient shortness breath due heart failure increase plasma level NT-pro-B-type natriuretic peptide ( NT-proBNP ) demonstrate . The use NT-proBNP biomarker heart failure patient present emergency department dyspnea might improve care reduce length hospital stay . To investigate effect NT-proBNP testing patient care time discharge NT-proBNP test randomize . In patient study group , NT-proBNP plasma level determine admission physician charge immediately receive result test . In patient control group blood sample physician recieve information NT-proBNP plasma level . In study investigate effect introduction NT-proBNP biomarker heart failure treatment , time discharge cost .</brief_summary>
	<brief_title>NT-proBNP Acute Dyspnea : Effects Treatment , Hospitalisation Costs</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<criteria>Age 18 year old Acute dyspnea prominent complaint Acute dyspnea due trauma Acute dyspnea due cardiogenic shock Renal failure require dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Diagnostic</keyword>
	<keyword>Natriuretic peptide</keyword>
	<keyword>NT-pro B-type natriuretic peptide</keyword>
	<keyword>Length stay</keyword>
	<keyword>Costs</keyword>
</DOC>